We have then conducted a retrospective, cohort study on the use of IgM-eIVIG in addition to antibiotic therapy in VLBW neonates with late onset sepsis as an hypothesis generator for future prospective clinical trials. The gene discussed is CD40LG; the disease is Sepsis.